Sophisticated HIV Diagnostics Adapted for Remote Areas
NIH funding leads to a new, low-cost molecular diagnostic instrument, with no electricity needed.
Read MorePosted by Steve Halasey | Dec 2, 2014 | Research |
NIH funding leads to a new, low-cost molecular diagnostic instrument, with no electricity needed.
Read MorePosted by Jenny Lower | Dec 1, 2014 | Biochemicals & Chemical Reagents, Infectious Diseases |
ViroStat, Portland, Me, has expanded its offering of hepatitis B reagents, including its Monotope and Omnitope antibodies and recombinant antigens.
Read MorePosted by Jenny Lower | Nov 24, 2014 | Emerging & Zoonotic Diseases, Infectious Diseases, POC Reagents & Test Kits, Point-of-Care |
The portable Firefly Dx system from PositiveID Corp can quickly detect pathogens such as ebola and E. coli in patients and in the environment, leading to more rapid and effective treatment.
Read MorePosted by Steve Halasey | Nov 18, 2014 | Molecular Diagnostics |
Singapore-based Vela Diagnostics has announced completion of the FDA listing of its next-generation sequencing system as a Class II medical device.
Read MorePosted by Steve Halasey | Nov 10, 2014 | Emerging & Zoonotic Diseases, Infectious Diseases |
US testing for chikungunya is unlikely to taper off during the fall and winter, as travelers returning from outbreak areas remain at risk.
Read More